Due to the increasing demand of process development and manufacture of novel product types we are pleased to announce that we secured the services of QP Robert Smith of Smiro Qualitas Ltd. Robert has over 25 years experience in the pharmaceutical industry, including his role as Global Head of Quality for the Clinical Pharmacy Research Services at Genzyme.  He is a past chair of both the ISPE Investigational Product Community of Practice and European Regional Steering Committee of Practice. In addition, Robert is a QP assessor for the Royal Pharmaceutical Society of Great Britain, assessing trainee QPs , for their eligibility to be placed on the UK QP register. He supports the CBF with his vast expertise in Clinical Trial Supplies, Quality Management Systems, validation and as a training advisor.

The CBF now has four QPs on the MHRA licence covering all aspects of innovative vaccines and other ground breaking products manufactured in our cleanrooms. They also support the Jenner Investigators in the early stages of planning and development for Phase I trials.